Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 BioPorto BIOPOR Apr 25, 2025 1.51 +2.03   
 Boozt BOOZTDKK Apr 25, 2025 55.10 -17.82   
 Brain+ BRAINP Apr 25, 2025 0.02 -2.94   
 Brd. Klee B KLEEB Apr 25, 2025 2 999.50 -3.23   
 Brdr. A & O Johansen Pref B AOJB Apr 25, 2025 84.80 +3.41   
 Brøndbyernes IF Fodbold BIF Apr 25, 2025 0.40 +2.31   
 Carlsberg A CARLA Apr 25, 2025 978.00 0.00   
 Carlsberg B CARLB Apr 25, 2025 889.20 -0.47   
 cBrain CBRAIN Apr 25, 2025 165.60 -1.08   
 Cemat CEMAT Apr 25, 2025 0.94 -0.05   
 Cessatech A/S CESSA Apr 25, 2025 12.64 -0.47   
 ChemoMetec CHEMM Apr 25, 2025 466.20 -1.44   
 Coloplast B COLOB Apr 25, 2025 725.20 +1.46   
 Columbus COLUM Apr 25, 2025 11.55 -0.43   
 Conferize CONFRZ Apr 25, 2025 0.02 0.00   
 Copenhagen Capital CPHCAPST Apr 25, 2025 5.40 +0.02   
 Copenhagen Capital 40 pct Pref 2032 CPHCAPPREF32 Apr 25, 2025 8.20 0.00   
 D/S Norden DNORD Apr 25, 2025 182.30 +8.45   
 Danish Aerospace Company DAC Apr 25, 2025 6.40 -1.54   
 Danske Andelskassers Bank DAB Apr 25, 2025 13.90 -3.11   
 Danske Bank DANSKE Apr 25, 2025 221.60 +1.65   
 Dantax DANT Apr 25, 2025 458.05 -1.99   
 Dataproces Group DATA Apr 25, 2025 8.88 -0.89   
 DecideAct ACT Apr 25, 2025 1.00 -25.93   
 Demant DEMANT Apr 25, 2025 233.40 +1.13   
 Det Ostasiatiske Kompagni A/S OKEAC Apr 25, 2025 9 050.00 0.00   
 DFDS DFDS Apr 25, 2025 89.00 0.00   
 Djurslands Bank DJUR Apr 25, 2025 621.20 -1.38   
 Donkey Republic DONKEY Apr 25, 2025 6.30 -3.08   
 DSV DSV Apr 25, 2025 1 280.00 +0.12   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.